Article Information
History
- August 31, 2020.
Article Versions
- Version 1 (July 23, 2020 - 04:48).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Guillermo Ruiz-Irastorza1,6,7,†,
- Jose-Ignacio Pijoan2,6,8,
- Elena Bereciartua3,6,7,
- Susanna Dunder4,6,
- Jokin Dominguez4,6,
- Paula Garcia-Escudero5,6,
- Alejandro Rodrigo4,6,
- Carlota Gomez-Carballo4,6,
- Jimena Varona4,6,
- Laura Guio3,6,7,
- Marta Ibarrola3,6,
- Amaia Ugarte1,6,
- Agustin Martinez-Berriotxoa4,6,7 and
- On behalf of the Cruces COVID Study Group*
- 1Autoimmune Diseases Research Unit. Service of Internal Medicine. Hospital Universitario Cruces
- 2Clinical Epidemiology Unit. Hospital Universitario Cruces
- 3Infectious Diseases Unit. Hospital Universitario Cruces
- 4Service of Internal Medicine. Hospital Universitario Cruces
- 5Service of Rheumatology. Hospital Universitario Cruces
- 6Biocruces Bizkaia Health Research Institute
- 7University of the Basque Country (UPV/EHU)
- 8CIBER of Epidemiology and Public Health (CIBERESP)
- ↵†CORRESPONDING AUTHOR: r.irastorza{at}outlook.es (GRI)
↵* Membership of the Cruces COVID Study Group is provided in the Acknowledgments.
Posted August 31, 2020.
SECOND WEEK METHYL-PREDNISOLONE PULSES IMPROVE PROGNOSIS IN PATIENTS WITH SEVERE CORONAVIRUS DISEASE 2019 PNEUMONIA: AN OBSERVATIONAL COMPARATIVE STUDY USING ROUTINE CARE DATA
